Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX)
Across 13 earnings reports since Mar 09, 2023, Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) has a clear post-earnings pattern. It moves ±6.21% on average after reporting and finishes higher 46.2% of the time. Its largest post-earnings gain was +0.4% (Mar 13, 2025) and its largest decline was -22.89% (Mar 26, 2026). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings reactions
How QNRX moved on each past earnings report.
Earnings Impact
Total Earnings
13
Avg Abs. Movement
±6.21%
Positive %
46.2%
Negative %
53.8%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☽ POST | +0% | open_in_new |
| Mar 26, 2026 | ☽ POST | -22.89% | open_in_new |
| Nov 06, 2025 | ☽ POST | +0% | open_in_new |
| Aug 07, 2025 | ☽ POST | +0% | open_in_new |
Earnings Count
13
Total earnings in dataset
Avg Abs. Movement
±6.21%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| ARS | 20260716 | open_in_new SEC.gov |
| DEF 14A | 20260716 | open_in_new SEC.gov |
| PRE 14A | 20260706 | open_in_new SEC.gov |
| 8-K | 20260623 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 424B3 | 20260602 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260602 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
Frequently asked about QNRX earnings
When does Quoin Pharmaceuticals, Ltd. American Depositary Shares report earnings next? expand_more
Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does QNRX stock move after earnings? expand_more
Over 13 reports, QNRX has moved an average of ±6.21% the session after earnings, closing higher 46.2% of the time.
What was QNRX's biggest post-earnings move? expand_more
QNRX's largest post-earnings gain on record was +0.4% on Mar 13, 2025, and its largest decline was -22.89% on Mar 26, 2026.
Where can I find Quoin Pharmaceuticals, Ltd. American Depositary Shares's SEC filings? expand_more
All of Quoin Pharmaceuticals, Ltd. American Depositary Shares's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07